Subsequent survival and gene pathway analyses in patients revealed that high levels of Sp1, β‐catenin, or p300 in HCC patients are associated with poor clinical outcomes and an enrichment of the Wnt/β‐catenin pathway. Here, EP300 is linked to hepatocellular carcinoma.